PHARMACY

FDA approves BI’s Pradaxa

BY Alaric DeArment

SILVER SPRING, Md. The Food and Drug Administration approved a drug for preventing strokes and blood clots in patients with abnormal heart rhythm, the agency said Tuesday.

 

The FDA announced the approval of Pradaxa (dabigatran etexilate) capsules, an anticlotting drug made by Boehringer Ingelheim for patients with atrial fibrillation, a type of abnormal heart rhythm that affects more than 2 million Americans.

 

 

“People with atrial fibrillation are at a higher risk of developing blood clots, which can cause a disabling stroke if the clots travel to the brain,” said Norman Stockbridge, director of the FDA Division of Cardiovascular and Renal Products.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Dr. Reddy’s to launch generic Prevacid

BY Allison Cerra

HYDERABAD, India Dr. Reddy’s disclosed on Tuesday it will market a generic peptic ulcer treatment.

Dr. Reddy’s lansoprazole delayed-release capsules will be available in 15-mg and 30-mg strengths, the drug maker said. The capsules are the generic version of Takeda’s Prevacid delayed-release capsules.

The FDA approved Dr. Reddy’s abbreviated new drug application for the drug on Oct. 15.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Kinney Drugs’ pharmacists address compliance issues

BY Alaric DeArment

GOUVERNEUR, N.Y. October is American Pharmacists Month, and Kinney Drugs has spent it educating patients about the medicines they take and how a relationship with their pharmacist can ensure the safety and efficacy of their therapies, the regional chain said Tuesday.

Poor medication adherence is estimated to cost the healthcare system $290 billion a year, according to the New England Healthcare Institute, while healthcare market research firm IMS Health estimated that only 25% to 30% of new prescriptions are properly taken.

“Compliance is driven by access and affordability, and it’s easy to be noncompliant when people have to make purchasing decisions, they can’t get to the pharmacy or they are not fully informed about their medication,” Kinney Drugs pharmacy director Mike Duteau said. “Pharmacists can make it easier for people to understand their health care and the value of taking medications as prescribed by their doctors.”

The company is highlighting some of the programs it offers, such as e-prescribing, prescription discount plans, automatic refills, flu immunizations and free Medicare Part D consultations. Kinney will sponsor a Community Medicine Take Back event on Wednesday, designed to help customers dispose of medications in a safe and environmentally sound way.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?